HAL vs VVOS · P/E 9.3, $19.05B cap vs rev $15.0M
Halliburton Company (HAL) versus Vivos Therapeutics Inc (VVOS) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Vivos Therapeutics Inc (VVOS) is a medical devices company listed on NASDAQ.
HAL does not have a complete income-statement cache yet.
Latest reported VVOS revenue for 2024-12-31 was $15.0M. Net income was -$11.1M. Revenue was up 8.9% from 2023-12-31 to 2024-12-31. VVOS currently screens at market cap $7.1M.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. VVOS currently screens at market cap $7.1M.
Not investment advice. Open the HAL and VVOS stock pages for the full models.
Not investment advice.